GRETCHEN FINK: Open Payments
NPI 1902012719 · COLUMBIA, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$269 in 9 payments from 5 companies in 2025. Trend: 2023 $14 · 2024 $0 · 2025 $269
Food & beverage: $269
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 3 | $138 |
| Neurocrine BioSciences, Inc. | 2 | $51 |
| Vanda Pharmaceuticals Inc. | 2 | $46 |
| Janssen Pharmaceuticals, Inc | 1 | $17 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
Products named: UZEDY, INGREZZA, FANAPT, INVEGA SUSTENNA, CAPLYTA.
Industry payments across MO — which companies pay providers there.
